the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart


Reducing the impact of cancer and autoimmune diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day


A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.


Jefferies Healthcare Conference, November 16, 2023 – presentation

Read More
17 November 2023

Nykode Therapeutics – 3Q 2023 Financial Results – presentation

Read More
15 November 2023

Nykode Therapeutics reports 3Q 2023 Financial Results

Read More
15 November 2023

Nykode Therapeutics – invitation to Q3 2023 financial results ...

Read More
09 November 2023

Nykode Therapeutics to Present at Jefferies Healthcare Conference

Read More
07 November 2023

Nykode Therapeutics ASA – Private Placement Completed

Read More
25 October 2023

Nykode Therapeutics ASA – Contemplated Private Placement

Read More
24 October 2023

Nykode Therapeutics – Update on process with the Norwegian ...

Read More
23 October 2023

Nykode Therapeutics to Present at the mRNA Cancer Vaccines ...

Read More
10 October 2023